BE636102A - - Google Patents
Info
- Publication number
- BE636102A BE636102A BE636102DA BE636102A BE 636102 A BE636102 A BE 636102A BE 636102D A BE636102D A BE 636102DA BE 636102 A BE636102 A BE 636102A
- Authority
- BE
- Belgium
- Prior art keywords
- virus
- infecting
- interfering
- inducing
- formation
- Prior art date
Links
- 241000700605 Viruses Species 0.000 claims description 70
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000005755 formation reaction Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 4
- 241000712461 unidentified influenza virus Species 0.000 claims description 3
- 102000014150 Interferons Human genes 0.000 claims description 2
- 108010050904 Interferons Proteins 0.000 claims description 2
- 206010046980 Varicella Diseases 0.000 claims description 2
- 201000006082 chickenpox Diseases 0.000 claims description 2
- 229940079322 interferon Drugs 0.000 claims description 2
- 241000991587 Enterovirus C Species 0.000 claims 1
- 230000002452 interceptive Effects 0.000 description 15
- 239000012530 fluid Substances 0.000 description 6
- 210000002969 Egg Yolk Anatomy 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 210000004027 cells Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010022000 Influenza Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052904 quartz Inorganic materials 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000004418 Durio kutejensis Nutrition 0.000 description 1
- 206010014599 Encephalitis Diseases 0.000 description 1
- 208000006572 Human Influenza Diseases 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- 229940035295 Ting Drugs 0.000 description 1
- 101700034535 Tpst Proteins 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011031 large scale production Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 101700079580 ttr-3 Proteins 0.000 description 1
- 229960005486 vaccines Drugs 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE636102A true BE636102A (de) |
Family
ID=202298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE636102D BE636102A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE636102A (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037441A1 (de) * | 1980-03-10 | 1981-10-14 | Seiji Arakawa | Pharmazeutische Zusammensetzungen zur zellulären Immunopotentialisation und als Antitumor-Mittel, Verfahren zu ihrer Herstellung und der darin verwendete Mikroorganismus |
-
0
- BE BE636102D patent/BE636102A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037441A1 (de) * | 1980-03-10 | 1981-10-14 | Seiji Arakawa | Pharmazeutische Zusammensetzungen zur zellulären Immunopotentialisation und als Antitumor-Mittel, Verfahren zu ihrer Herstellung und der darin verwendete Mikroorganismus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cromeans et al. | Detection of hepatitis A virus RNA in oyster meat | |
| Grabow | Bacteriophages: update on application as models for viruses in water | |
| Abad et al. | Disinfection of human enteric viruses in water by copper and silver in combination with low levels of chlorine | |
| Gerba et al. | Waterborne gastroenteritis and viral hepatitis | |
| EP0841942A1 (de) | Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff | |
| Shen et al. | Sequence and structural characterization of great salt lake bacteriophage CW02, a member of the T7-like supergroup | |
| CN114774372B (zh) | 柯萨奇病毒a10型毒株及其疫苗和应用 | |
| Tian et al. | Effects of hydrostatic pressure on the structure and biological activity of infectious bursal disease virus | |
| CA2979939A1 (en) | Cellulose nanofiber membrane, its preparation and its use | |
| Betancourt et al. | Rethinking the significance of reovirus in water and wastewater | |
| BE636102A (de) | ||
| WO2023246639A1 (zh) | 柯萨奇病毒a6型毒株及其免疫原性组合物和应用 | |
| CN116355982A (zh) | 一种米糠蛋白水解物及其制备方法与应用 | |
| Oshima et al. | The removal of phages T1 and PP7, and poliovirus from fluids with hollow-fiber ultrafilters with molecular weight cut-offs of 50 000, 13 000, and 6000 | |
| CN1876839A (zh) | 诺瓦克病毒和轮状病毒多重rt－pcr检测方法及试剂盒 | |
| WO1999047648A2 (fr) | Milieu et procede de propagation et de multiplication virales | |
| CN116162601A (zh) | 一种流感病毒裂解疫苗的制备方法 | |
| CN111172121A (zh) | 一种塞内卡病毒的纯化浓缩方法 | |
| Eiser et al. | Molecular cooking: physical transformations in Chinese ‘century’eggs | |
| RU2294760C2 (ru) | Вакцина инактивированная сорбированная против ящура типа а | |
| RU2773659C1 (ru) | Штамм А 2205/G IV вируса ящура Aphtae epizooticae типа А для изготовления биопрепаратов для диагностики и специфической профилактики ящура типа А | |
| Karim et al. | Low-Cost Production of Chitosan Biopolymer from Seafood Waste: Extraction and Physiochemical Characterization | |
| JP5084214B2 (ja) | Ｉｐｖワクチン | |
| RU2753969C1 (ru) | Способ опосредованного определения полноты инактивации антигена вируса ящура в сырье для вакцины с применением обратно-транскриптазной полимеразной цепной реакции в режиме реального времени при амплификации большеразмерного фрагмента | |
| Le Guyader et al. | Comparative study of the behaviour of poliovirus in sterile seawater using RT-PCR and cell culture |